ClinConnect ClinConnect Logo
Search / Trial NCT06682871

Breastfeeding Evaluation of Puerperal Women Who Had Cesarean Delivery in Our Hospital

Launched by KONYA CITY HOSPITAL · Nov 8, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Post Cesarean Analgesia Breastfeeding Latch Score Visuel Pain Score

ClinConnect Summary

This clinical trial is looking at how different methods of pain relief after a cesarean delivery can affect breastfeeding for new mothers. The researchers want to understand if a specific pain relief technique called TAP block can help mothers feel better and make it easier for them to start breastfeeding their babies. The World Health Organization recommends that babies should be exclusively breastfed for at least six months because it’s very beneficial for their health and development.

To participate in this trial, women aged 18 to 45 who are scheduled for an elective cesarean delivery and expect to stay in the hospital for at least three nights may be eligible. Participants will need to be able to use a special system that allows them to manage their own pain relief after surgery. Throughout the trial, mothers can expect support in their breastfeeding journey while receiving effective pain management. This study is important because it aims to find ways to improve the breastfeeding experience for mothers who have had cesarean births, which can often be more challenging than for those who have vaginal deliveries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Written informed consent;
  • 18-45 years old;
  • ASA Physical Status 1-3;
  • Scheduled for elective cesarien delivery;
  • Anticipated hospitalization of at least three nights;
  • Expected requirement for parenteral opioids for at least 72 hours for postoperative pain;
  • Able to use IV PCA systems.
  • Exclusion Criteria:
  • Hepatic disease, e.g. twice the normal levels of liver enzymes;
  • Kidney disease, e.g. twice the normal level of serum creatinine;
  • Bupivacaine sensitivity or known allergy;
  • Anticoagulants considered to be a contraindication for TAP blocks;
  • Surgeries with high port sites

About Konya City Hospital

Konya City Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a focus on collaborative research, the hospital integrates state-of-the-art facilities and a multidisciplinary team of experienced professionals. By participating in clinical trials, Konya City Hospital aims to contribute to the development of new therapies and enhance the understanding of various medical conditions, ultimately benefiting both the local community and the broader medical field.

Locations

Konya, , Turkey

Patients applied

0 patients applied

Trial Officials

Ramazan Keçeci, Specialist

Principal Investigator

Konya City Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported